The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 14, 2006

Filed:

Oct. 30, 2000
Applicants:

Martin E. Davis, Tonka Bay, MN (US);

Anand Rao, Savage, MN (US);

Sylvie Gauthier, Charny, CA;

Yves Pouliot, Charny, CA;

Line Gourley, Québec, CA;

Anne-francoise Allain, Saint-Lambert de Lauzon, CA;

Inventors:

Martin E. Davis, Tonka Bay, MN (US);

Anand Rao, Savage, MN (US);

Sylvie Gauthier, Charny, CA;

Yves Pouliot, Charny, CA;

Line Gourley, Québec, CA;

Anne-Francoise Allain, Saint-Lambert de Lauzon, CA;

Assignee:

Davisco Foods International, LeSueur, MN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12P 21/06 (2006.01); C12N 9/60 (2006.01); A01N 37/18 (2006.01);
U.S. Cl.
CPC ...
Abstract

Enzymatic digests of whey protein concentrates were prepared using animal, bacterial and fungal proteases, and evaluated for antihypertensive activities. The highest ACE-inhibitory activity was obtained with the purified peptide β-1g (f142–148) obtained by chemical synthesis, for which an ICvalue of 0.04 mg powder.mlwas found. The hydrolysates derived from BiPRO™ whey protein isolate and β-1g both gave higher antihypertensive activities (ICvalues of 0.29 to 0.90 mg powder.ml) than the other hydrolysates tested (ICvalues of 0.96 and 1.30 mg powder.ml). The recovered hydrolysate can be used to treat hypertension in mammals such as humans and domestic pets such as dogs and cats.


Find Patent Forward Citations

Loading…